The impact of different anticoagulants and antiplatelets regimens on acute epistaxis outcomes.

ABSTRACT:

Background

The impact of anticoagulants (AC) and antiplatelets (AP) on the management of acute epistaxis remains unclear. This study investigated the association between AC/AP therapy and treatment outcomes in patients with acute epistaxis.

Methodology

A retrospective analysis of patients presented to the otolaryngology emergency room with acute epistaxis (2014-2022). Patients were categorized based on their regular medications: AP, dual AP therapy (DAPT), new oral anticoagulants (NOAC), vitamin K antagonists (VKA), or no regular AC/AP use (control group). Outcome measures included rates of minor interventions (chemical or electrical cautery, nasal tamponade), major interventions (endoscopic ligation, embolization), recurrent emergency department visits, admission rates, and

SUBMITTER: Zloczower E 

PROVIDER: S-EPMC11393048 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature